Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 9/20 | 0.40 |
| ▸ | CDK2 | P24941 | 7/20 | 0.40 |
| ▸ | SGK1 | O00141 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | PTPRB | P23467 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4294379 | 0.91 | AKT1 (0.41) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4294376 | 0.90 | AKT1 (0.40) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4294382 | 0.90 | AKT1 (0.40) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4298351 | 0.90 | AKT1 (0.38) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4298357 | 0.90 | AKT1 (0.38) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4291758 | 0.90 | AKT1 (0.40) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4291766 | 0.90 | AKT1 (0.40) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4301332 | 0.90 | AKT1 (0.40) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4301329 | 0.90 | AKT1 (0.40) | AKT1CDK2SGK1ROCK2PTPRB | |
| SCHEMBL4291762 | 0.90 | AKT1 (0.40) | AKT1CDK2SGK1ROCK2PTPRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7514566-B2 | Thiazole compounds and methods of use | AMGEN, INC. (US) | 2009-04-07 | — | — | US | disclosed |